Janssen teams with CureVac to develop influenza vaccine
Janssen has partnered with CureVac to use its messenger RNA (mRNA) platform to develop an influenza vaccine.
Archives for October 8, 2013
Biocon: Policy and infrastructure hold back Indian biomanufacturing
India’s biomanufacturing sector has immense potential, but policy, infrastructure and finance-related issues are holding it back, say both Biocon and analysts.